Figure 1.
Treatment responses with minimal residual disease status. MRD was assessed by 10-color flow cytometry at both planned response assessments: midtherapy after cycle 8 (A) and end of treatment 2 months after completion of cycle 14 (B). The limit of detection for MRD is less than 1 × 10−4. BM, bone marrow; PB, peripheral blood.